Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
Diabet Med ; 31(7): e25-8, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24698085

RESUMEN

BACKGROUND: Purulent pericarditis is an acute and fulminant disease characterized by pus accumulation in the pericardial space. Its incidence has declined substantially and the common pathogen has changed since the beginning of the antibiotic era; however, it is still found in some patients with immunocompromised conditions. CASE REPORT: We report a rare case in which the onset of diabetes mellitus presented as extremely high HbA1c concentration, ketoacidosis, multi-site abscesses and purulent pericarditis. After antibiotic therapy and pericardiocentesis, the purulent pericarditis still did not resolve and further intrapericardial thrombolytic therapy also failed. Finally, this patient was treated successfully by surgical debridement and pericardiectomy. CONCLUSION: In the immunocompromised state of severe hyperglycaemia, purulent pericarditis is a possible complication of uncontrolled infection. If purulent pericarditis cannot be cured using non-surgical treatments, such as antibiotic therapy, pericardiocentesis and intrapericardial thrombolytic therapy, a surgical pericardiectomy should be considered to avoid morbidity and mortality.


Asunto(s)
Absceso/diagnóstico , Absceso/terapia , Antibacterianos/uso terapéutico , Desbridamiento , Diabetes Mellitus Tipo 2/complicaciones , Cetosis/etiología , Pericardiectomía , Pericarditis/diagnóstico , Pericarditis/terapia , Absceso/patología , Diabetes Mellitus Tipo 2/diagnóstico , Ecocardiografía , Fibrinolíticos/uso terapéutico , Humanos , Cetosis/terapia , Masculino , Persona de Mediana Edad , Pericardiocentesis , Supuración , Terapia Trombolítica , Resultado del Tratamiento
2.
Pharmacogenomics J ; 10(6): 537-44, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20066004

RESUMEN

Because angiotensin-converting enzyme (ACE) activity is implicated widely in biological systems, we aimed to identify its novel quantitative trait loci for the purposes of understanding ACE activity regulation and pharmacogenetics relating to ACE inhibitor (ACEI). We performed a two-stage genome-wide association study: (1) from 400 young-onset hypertension (YOH) subjects and (2) a confirmation study with an additional 623 YOH subjects. In the first stage, eight single nucleotide polymorphisms (SNPs) of the ACE structural gene and one SNP of ABO genes were significantly associated with ACE activity. SNP rs4343 in exon17 near the well-known insertion/deletion polymorphism had the strongest association. We confirmed in the second stage that three SNPs: rs4343 in ACE gene (P=3.0 x 10⁻²5), rs495828 (P=3.5 x 10⁻8) and rs8176746 (P=9.3 x 10⁻5) in ABO gene were significantly associated with ACE activity. We further replicated the association between ABO genotype/blood types and ACE activity in an independent YOH family study (428 hypertension pedigrees), and showed a potential differential blood pressure response to ACEI in subjects with varied numbers of ACE-activity-raising alleles. These findings may broaden our understanding of the mechanisms controlling ACE activity and advance our pharmacogenetic knowledge on ACEI.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Peptidil-Dipeptidasa A/genética , Sitios de Carácter Cuantitativo , Sistema del Grupo Sanguíneo ABO/genética , Adulto , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Presión Sanguínea/genética , Femenino , Estudio de Asociación del Genoma Completo , Humanos , Hipertensión/tratamiento farmacológico , Hipertensión/genética , Masculino , Peptidil-Dipeptidasa A/sangre , Polimorfismo de Nucleótido Simple
3.
Clin Nephrol ; 72(6): 457-67, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19954723

RESUMEN

AIM: The angiotensin II Type 1 receptor (AT1R) A1166C (rs5186) genez polymorphism is equivocally associated with the patients' susceptibility to chronic kidney disease or end-stage renal disease. We conducted a prospective study to investigate the influence of AT1R A1166C gene polymorphism on the quantitative changes of renal function. METHOD: Of 1500 people screened, 112 non-diabetic normotensive elderly Chinese were recruited and received biochemistry examination at the baseline, at the second and fourth year follow-up. Serum creatinine and calculated renal parameters, using Cockroft-Gault (CG) formula, Modification of Diet in Renal Disease (MDRD) Study and abbreviated MDRD (abMDRD) equation, were used to evaluate renal function and their progression. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism. RESULT: Age was 71.9 +/- 3.7 years (range 60 - 81). Serum creatinine, CG creatinine clearance (CrCl), MDRD and abMDRD glomerular filtration rate (GFR) were significantly decreased at the 2 and 4-year follow-up (all p < 0.001). The magnitude of 4-year decline of above four renal parameters was significantly higher in subjects carrying the AT1R AA genotype than C-allele carriers (p = 0.014, 0.033, 0.008 and 0.014 for creatinine, CG CrCl, MDRD and abMDRD GFR, respectively). This association was still significant in multivariate analyses (p = 0.019, 0.045, 0.035 and 0.018, respectively). CONCLUSION: This longitudinal study showed that the aging process was associated with decline of renal function in the healthy elderly. The AT1R A1166C gene polymorphism might modulate these changes in the Chinese. This provides further knowledge essential in the assessment of renal disease and determination of renal function in the older subjects.


Asunto(s)
Envejecimiento/fisiología , ADN/genética , Predisposición Genética a la Enfermedad , Fallo Renal Crónico/genética , Polimorfismo Genético , Receptor de Angiotensina Tipo 1/genética , Anciano , Anciano de 80 o más Años , Alelos , Femenino , Estudios de Seguimiento , Genotipo , Humanos , Fallo Renal Crónico/sangre , Fallo Renal Crónico/epidemiología , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Prevalencia , Pronóstico , Receptor de Angiotensina Tipo 1/sangre , Valores de Referencia , Estudios Retrospectivos , Taiwán/epidemiología , Factores de Tiempo
4.
Int J Obes (Lond) ; 32(2): 268-74, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17878891

RESUMEN

OBJECTIVE: Epicardial and abdominal adipose tissues have recently been demonstrated to play inflammatory roles in coronary atherosclerosis. We sought to compare tissue adipocytokine levels of these two anatomically distinct adipose stores in patients with and without coronary artery diseases (CAD). DESIGN: Samples of abdominal and epicardial fat tissues were harvested to detect the levels of adipocytokines and proinflammatory mediators. SUBJECTS: Forty-six patients with CAD who underwent coronary artery bypass surgery and 12 non-CAD control subjects who underwent other types of open-heart surgery. MEASUREMENTS: Tissue levels of adipocytokines (adiponectin, leptin and visfatin) and proinflammatory mediators (tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6)) were determined by enzyme-linked immunosorbent assay. RESULTS: Tissue levels of TNF-alpha, IL-6, leptin and visfatin were significantly higher in CAD patients relative to control subjects. In addition, significantly higher tissue levels of these four cytokines from abdominal fat depots were found compared to those from epicardial fat in CAD patients. Conversely, in comparison with control subjects, tissue levels of adiponectin were significantly reduced in CAD patients with a significantly lower tissue levels of abdominal than epicardial fat depots demonstrated. CONCLUSION: Abdominal adiposity may play more significant role than epicardial fat in the pathogenesis of coronary atherosclerosis.


Asunto(s)
Adipoquinas/metabolismo , Tejido Adiposo/metabolismo , Enfermedad de la Arteria Coronaria/metabolismo , Mediadores de Inflamación/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Enfermedad de la Arteria Coronaria/etiología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/metabolismo
5.
Clin Exp Med ; 6(2): 94-8, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16820998

RESUMEN

Acute contrast medium-induced nephrotoxicity was estimated in 3%-12% of patients receiving cardiac angiography, especially in advanced age, renal insufficiency and diabetic patients. As intrinsic renal antioxidant enzyme activities may play a crucial role in defence against renal oxidant injury, this study was designed to investigate the acute effect of ionic high osmolar diatrizoate meglumine/diatrizoate sodium on renal antioxidant activities in normal or streptozotocin (STZ)-induced diabetic rats at two time points (1 h and 24 h). A total of 40 Wistar rats were separated to normal and STZ-induced diabetic groups. Ten of each group were injected with diatrizoate (10 ml/kg) via tail vein and 10 with 10 ml/kg of 0.9% NaCl as control. This study shows that diabetic rats had higher renal glutathione peroxidase (GPx) activities than those of normal rats. GPx activities decreased significantly after diatrizoate injection at the first hour (717.4+/-104.0 to 578.6+/-92.1 mU/mg in the diabetic group, 466.4+/-30.6 to 371.4+/-75.5 mU/mg in the normal group, all P=0.032) but the difference faded 24 h later. The increase of superoxide dismutase (SOD) activities was enhanced (673.5+/-100.2 to 750.4+/-129.8 U/mg, P=0.04) in the normal group, but not in the diabetic group (624.1+/-156.6 to 671.1+/-136.7 U/mg, P=0.15) after diatrizoate injection at the first hour. At 24 h, renal SOD activities were still significantly higher in the diatrizoate injection group. In summary, intrinsic renal antioxidant activities are adapted in STZ-induced diabetes and ionic high osmolar diatrizoate could modify their activities. Furthermore, diabetics have abnormal response of renal antioxidant activities by contrast media and are at risk for contrast-mediated nephrotoxicity.


Asunto(s)
Medios de Contraste , Diabetes Mellitus Experimental/enzimología , Glutatión Peroxidasa/metabolismo , Riñón/enzimología , Superóxido Dismutasa/metabolismo , Animales , Concentración Osmolar , Ratas , Ratas Wistar , Estreptozocina
6.
Am J Cardiol ; 85(7): 882-5, A9, 2000 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-10758933

RESUMEN

In patients with left Kent bundle, the initial phase of isovolumic relaxation flow was directed basally at pre-excited beats, but apically at nonpreexcited beats or after successful ablation of the Kent bundle. This suggests an important role of the left ventricular activation sequence in the direction of isovolumic relaxation flow.


Asunto(s)
Ventrículos Cardíacos/fisiopatología , Función Ventricular Izquierda/fisiología , Síndrome de Wolff-Parkinson-White/fisiopatología , Adulto , Velocidad del Flujo Sanguíneo , Ecocardiografía Doppler de Pulso , Electrocardiografía , Femenino , Ventrículos Cardíacos/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Contracción Miocárdica , Volumen Sistólico , Síndrome de Wolff-Parkinson-White/diagnóstico por imagen
7.
Am J Cardiol ; 71(5): 405-8, 1993 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-8430627

RESUMEN

The electrophysiologic effects of intravenous verapamil (0.15 mg/kg) and oral sustained-release verapamil (verapamil-SR) (240 mg once daily for 7 days) were studied in 17 patients with paroxysmal supraventricular tachycardia (SVT). Ten patients had atrioventricular (AV) nodal reentrant tachycardia and 7 had AV reciprocating tachycardia involving an accessory AV pathway. Both preparations significantly prolonged anterograde effective refractory period of the AV node and depressed the retrograde AV nodal conduction system. The sinus cycle length, and atrial and ventricular effective refractory periods were prolonged after oral verapamil-SR. Furthermore, oral verapamil-SR depressed retrograde accessory pathway conduction which was not interfered with by intravenous verapamil. Intravenous verapamil and oral verapamil-SR prevented induction of sustained SVT in 12 of 17 (71%) and 10 of 17 (59%) patients, respectively. Follow-up study with oral verapamil-SR 240 mg once daily in 15 patients for 19 +/- 6 months revealed that among the 8 patients without induction of sustained SVT, 7 have been free of symptomatic arrhythmia; only 1 patient had occasional SVT attacks. For the 7 patients with induction of sustained SVT, 3 patients failed to respond to oral verapamil-SR, 1 patient became symptom free, and the remaining 3 patients had less frequent SVT attacks. Thus, immediate intravenous verapamil testing predicts the electrophysiologic results of oral verapamil-SR therapy, and oral verapamil-SR once daily may be used for long-term prophylaxis of SVT with better patient compliance.


Asunto(s)
Sistema de Conducción Cardíaco/efectos de los fármacos , Taquicardia Paroxística/tratamiento farmacológico , Taquicardia Supraventricular/tratamiento farmacológico , Verapamilo/administración & dosificación , Administración Oral , Estimulación Cardíaca Artificial , Preparaciones de Acción Retardada , Electrocardiografía , Femenino , Estudios de Seguimiento , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Taquicardia Paroxística/epidemiología , Taquicardia Supraventricular/epidemiología , Verapamilo/sangre , Verapamilo/uso terapéutico
8.
Br J Pharmacol ; 119(1): 7-14, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8872350

RESUMEN

1. The beta-adrenoceptor blocking and calcitonin gene-related peptide (CGRP)-releasing properties of capsinolol (N-[4-(2-hydroxy-3 (isopropylamino) propoxy)-3-methoxybenzyl]-nonanamide), derived from nonivamide, were investigated under in vivo and in vitro conditions. 2. Capsinolol (0.1, 0.5, 1.0 mg kg-1, i.v.), as well as (+/-)-propranolol, produced a dose-dependent bradycardia response and a temporary pressor action in urethane-anaesthetized normotensive Wistar rats. These cardiovascular effects were different from the vagus reflex and parasympathetic efferent effects shown by capsaicin (0.1 mg kg-1, i.v.) in the rat. 3. Capsinolol (1.0 mg kg-1) inhibited the tachycardia effects induced by (-)-isoprenaline, but had no blocking effect on the arterial pressor responses induced by (-)-phenylephrine. The findings suggest that capsinolol possesses beta-adrenoceptor blocking activity, but it has no alpha-adrenoceptor blocking activity. 4. In guinea-pig isolated tissues, capsinolol (10(-8) to 10(-6) M) antagonized (-)-isoprenaline-induced positive chronotropic and inotropic effects of the atria and tracheal relaxation responses in a concentration-dependent manner. The parallel shift to the right of the concentration-response curve of (-)-isoprenaline suggests capsinolol is a beta-adrenoceptor competitive antagonist. 5. Capsinolol (10(-5) to 10(-4) M) exhibited a positive cardiotonic effect that was not inhibited by (+/-)-propranolol and reserpine, but was inhibited by capsazepine (10(-6) M) and CGRP8-37 (10(-6) M). This effect was independent of intrinsic sympathomimetic effects. 6. An immunoassay of released CGRP from guinea-pig isolated perfused heart indicated that capsinolol increases the release of CGRP and thus produces positive cardiotonic effects. 7. In conclusion, capsinolol is a non-selective beta-adrenoceptor antagonist with capsaicin-like cardiotonic properties unrelated to traditional intrinsic sympathomimetic effects. It is suggested that capsinolol causes CGRP release from cardiac sensory neurones via a non-adrenergic mechanism and then activates CGRP receptors on cardiac muscle.


Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Péptido Relacionado con Gen de Calcitonina/metabolismo , Capsaicina/análogos & derivados , Miocardio/metabolismo , Antagonistas de Receptores Adrenérgicos beta 1 , Antagonistas de Receptores Adrenérgicos beta 2 , Animales , Presión Sanguínea/efectos de los fármacos , Bradicardia/inducido químicamente , Péptido Relacionado con Gen de Calcitonina/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/inmunología , Capsaicina/farmacología , Cardiotónicos/farmacología , Relación Dosis-Respuesta a Droga , Cobayas , Atrios Cardíacos/efectos de los fármacos , Atrios Cardíacos/metabolismo , Técnicas In Vitro , Isoproterenol/farmacología , Masculino , Relajación Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Miocardio/inmunología , Propranolol/farmacología , Ratas , Ratas Wistar , Taquicardia/inducido químicamente , Tráquea/efectos de los fármacos
9.
Chest ; 99(4): 887-91, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2009790

RESUMEN

To assess the effects of intravenous aminophylline on the sinus node, 12 patients with clinical and Holter monitor-documented sick sinus syndrome were studied (1) during the control state, (2) after pharmacologic autonomic blockade and (3) 5 min after intravenous administration of aminophylline. The effects of aminophylline on sinus node function were compared with those after pharmacologic autonomic blockade. No significant improvement of sinus node function was found after intravenous aminophylline administration with a mean sinus cycle length and a mean maximum CSRT of 968 +/- 218 and 1832 +/- 1036 ms, respectively. The mean serum theophylline level was 10.9 +/- 1.7 micrograms/ml. Since aminophylline is an adenosine receptor antagonist, these findings suggest that intrinsic adenosine may not play an important role in pathogenesis in patients with chronic and advanced sick sinus syndrome.


Asunto(s)
Adenosina/fisiología , Aminofilina/farmacología , Antagonistas Purinérgicos , Síndrome del Seno Enfermo/etiología , Nodo Sinoatrial/efectos de los fármacos , Adenosina/antagonistas & inhibidores , Estimulación Cardíaca Artificial , Electrocardiografía , Electrofisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Propranolol
10.
Invest Radiol ; 27(1): 35-9, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1733878

RESUMEN

Myocardial ATP, ADP, and AMP were measured from cardiac biopsy in 11 dogs after intracoronary injection of 6 mL of sodium-meglumine diatrizoate (SMD), iohexol (IOH), or 0.9% sodium chloride (NaCl), and in three of the dogs at baseline before any injection. The ATP at baseline and after SMD, IOH, and 0.9% NaCl were 5.39 +/- 0.41, 3.72 +/- 0.70, 5.52 +/- 0.82, and 5.44 +/- 1.40 mumol/g wet weight, respectively. There were significant differences between SMD and IOH (P less than .02), and between SMD and 0.9% NaCl (P less than .05). The energy charge of SMD was 0.82 +/- 0.08, which differed from 0.89 +/- 0.02 for NaCl or 0.9 +/- 0.05 for baseline (P less than .05), but not from 0.85 +/- 0.04 for IOH. In conclusion, diatrizoate caused significant depletions in ATP stores in comparison with iohexol, but there was no significant difference with respect to energy charge. Nonionic contrast media would be preferable for coronary arteriography in patients whose high-energy stores might be depleted from severe ischemia.


Asunto(s)
Diatrizoato de Meglumina/farmacología , Metabolismo Energético/efectos de los fármacos , Yohexol/farmacología , Miocardio/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Vasos Coronarios , Diatrizoato de Meglumina/administración & dosificación , Perros , Femenino , Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Inyecciones Intraarticulares , Yohexol/administración & dosificación , Masculino
11.
Invest Radiol ; 30(1): 28-32, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7759213

RESUMEN

RATIONALE AND OBJECTIVES: This study was designed to compare the effects of ionic contrast medium (CM), Renografin-76 (R76), and nonionic CM, Omnipaque-350 (OM350), on coronary hemodynamics and myocardial metabolism. METHODS: In 10 open-chest, atrial-paced dogs, 4 mL of R76 and OM350 were injected into the left anterior descending coronary artery. Coronary blood flow (CBF), myocardial oxygen consumption (MVO2), lactate extraction (LE), left ventricular (LV) dp/dt, and aortic systolic pressure (AOP) were measured. RESULTS: The maximal CBF changes caused by OM350 and R76 were 23.7 +/- 3.3 mL/minute and 18.3 +/- 3.3 mL/minute (NS), respectively. OM350 produced an increase in LV dp/dt by 378 +/- 85 mm Hg/second, which was different from -244 +/- 65 mm Hg/second by R76 (P < .05). The changes in MVO2 and LE after OM350 injection were 2.6 +/- 0.6 mL/minute and 10.2 +/- 5 microM/minute, respectively; those were different from -0.1 +/- 0.4 mL/minute, and -7.7 +/- 5.1 microM/minute after R76 injection (P < .05). CONCLUSION: Although both agents increased CBF, they appeared to act by different mechanisms. That a direct coronary vasodilator effect is the main action of R76 on coronary vascular response is suggested by decreasing myocardial contractility and oxygen consumption. However, OM350, by enhancing both parameters, may augment CBF at least in part by autoregulation.


Asunto(s)
Medios de Contraste/farmacología , Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Miocardio/metabolismo , Animales , Circulación Coronaria/efectos de los fármacos , Perros , Femenino , Corazón/fisiología , Lactatos/metabolismo , Ácido Láctico , Masculino , Consumo de Oxígeno/efectos de los fármacos
12.
Laryngoscope ; 111(1): 131-6, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11192881

RESUMEN

OBJECTIVES/HYPOTHESIS: Nasopharyngeal carcinoma (NPC) is a common malignant neoplasm of the head and neck that occurs in people in the southeastern Asian area, including Taiwan. The significant association of p53 expression in NPC suggested that p53 overexpression seemed to occur at an early stage in the development of NPC. Alterations of p53 status were probably the most commonly encountered in head and neck carcinomas, and there was extensive evidence that p53 status might determine tumor response to therapy. Ionizing radiation was studied extensively for the relationship between its damaging effect and p53 status in human cancer cells. STUDY DESIGN: This study was carried out to investigate whether there was any correlation between overexpression of p53 protein and locoregional tumor response in patients with NPC treated with 7000 cGy of radiotherapy. METHODS: Sixty-eight patients (50 males, 18 females) with NPC who were diagnosed and treated with radiotherapy were studied prospectively. Before they had received a radiation dose of 7000 cGy in 35 fractions, five fractions a week, p53 status from a nasopharyngeal biopsy was studied using immunohistochemical staining (IHC). RESULTS: The locoregional response rate of primary tumor was analyzed statistically. Forty-seven patients (69.1%) showed positive p53 staining in their tumors. There were 5 positive stains in 6 squamous cell carcinomas (SCC; 83.3%), 34 positive in 53 non-keratinizing carcinomas (NKC; 64.2%), and 8 positive in 9 undifferentiated carcinomas (UC; 88.9%). The mean ages for patients with three different histopathologies were 48.5, 46.1, and 61.1 years. There were 8 patients (7 positive stains, 1 negative stain) with residual tumor after radiotherapy and all were NKC (6 males, 2 females). Therefore, the clinical response rate of primary tumor was 85.1% in positive p53 immunostaining (40 of 47 cases), 95.2% in those with no immunostaining (20 of 21 cases); the former was poorer in locoregional tumor response than the latter, but there was no significant difference (P > .05, chi2 test). CONCLUSIONS: We conclude that there is no statistically significant correlation in locoregional response of primary tumor between p53 overexpression and radiotherapy in patients with NPC (P > .05, Fisher exact test).


Asunto(s)
Carcinoma/radioterapia , Regulación Neoplásica de la Expresión Génica/genética , Neoplasias Nasofaríngeas/radioterapia , Proteína p53 Supresora de Tumor/genética , Adolescente , Adulto , Factores de Edad , Anciano , Anticuerpos Monoclonales , Carcinoma/genética , Carcinoma/patología , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/radioterapia , Distribución de Chi-Cuadrado , Fraccionamiento de la Dosis de Radiación , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neoplasias Nasofaríngeas/genética , Neoplasias Nasofaríngeas/patología , Estadificación de Neoplasias , Neoplasia Residual , Estudios Prospectivos , Dosificación Radioterapéutica , Inducción de Remisión , Factores Sexuales , Resultado del Tratamiento
13.
Water Res ; 35(8): 2017-21, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11337849

RESUMEN

Spent caustic from olefin plants contains much H2S and some mercaptans, phenols and oil. A new treatment process of spent caustic by neutralization followed by oxidation with Fenton's reagent (Fe2+/H2O2) was successfully developed. Over 90% of dissolved H2S were converted to gas phase by neutralization at pH = 5 and T = 70 degrees, and the vent gas stream could be introduced to sulfur recovery plant. The neutralized liquid was oxidized with OH. free radical, which was provided by a Fenton's reagent. The residual sulfides in the neutralized spent caustic were oxidized to less than 0.1 mg/L. The total COD removal of spent caustic is over 99.5% and the final COD value of the effluent can be lower than 100 mg/L under the following oxidation conditions: reaction time = 50 min, T = 90 degrees, Fe2+ = 100 mg/L, and a stoichiometric H2O2/COD = 1.1. The value is better than the 800 mg/L value obtained by common WAO process. The optimum pH of the Fenton reaction is around 2 for this process, and the oxidation step can maintain a pH value in the range of 1.8-2.4. Moreover, the iron catalyst can be recycled without affecting process effectiveness thus preventing secondary pollution.


Asunto(s)
Cáusticos , Peróxido de Hidrógeno , Residuos Industriales , Hierro , Contaminantes Químicos del Agua , Purificación del Agua/métodos , Alquenos , Diseño de Equipo , Sulfuro de Hidrógeno , Oxidación-Reducción , Purificación del Agua/instrumentación
14.
Int J Clin Pract Suppl ; (145): 40-5, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15617458

RESUMEN

A multicentre, randomised, double-blind, double-dummy, parallel-group, dose-titration study was conducted to determine the efficacy and tolerability of telmisartan 40-80 mg once daily compared with losartan 50-100 mg once daily in 180 Taiwanese patients with mild-to-moderate essential hypertension. After an initial 2-week placebo run-in phase, patients were randomised in a double-blind, double-dummy fashion to receive either telmisartan 40 mg or losartan 50 mg. If blood pressure control (diastolic blood pressure [DBP] <90 mmHg or > or = 10 mmHg reduction in DBP) was achieved after 4 weeks, the dose was maintained for the second 4 weeks of the active treatment phase; if not, the dose was doubled to telmisartan 80 mg or losartan 100 mg, respectively, for the second 4 weeks of double-blind treatment. Telmisartan 40-80 mg (n = 86) was as effective as losartan 50-100 mg (n = 90) in reducing trough seated DBP (11.1 vs. 8.7 mmHg, p = 0.144), and was significantly more effective than losartan in reducing trough seated systolic blood pressure (SBP) (22.1 vs. 16.5 mmHg, p = 0.032) and standing SBP (21.0 vs. 16.3 mmHg, p = 0.033). Significantly fewer patients treated with telmisartan than those treated with losartan required uptitration after 4 weeks' treatment (32.6% vs. 61.5%, p = 0.001). Both telmisartan and losartan were well tolerated.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/administración & dosificación , Inhibidores de la Enzima Convertidora de Angiotensina/administración & dosificación , Antihipertensivos/administración & dosificación , Bencimidazoles/administración & dosificación , Benzoatos/administración & dosificación , Hipertensión/tratamiento farmacológico , Losartán/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Bloqueadores del Receptor Tipo 1 de Angiotensina II/efectos adversos , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Antihipertensivos/efectos adversos , Bencimidazoles/efectos adversos , Benzoatos/efectos adversos , Presión Sanguínea , Método Doble Ciego , Femenino , Humanos , Hipertensión/fisiopatología , Losartán/efectos adversos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Telmisartán
15.
Kaohsiung J Med Sci ; 14(3): 177-80, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9849045

RESUMEN

We report on a 68-year-old male case of mitral regurgitation secondary to aortic regurgitation diagnosed using transthoracic echocardiography. A different mechanism of mitral regurgitation secondary to aortic regurgitation is demonstrated in this report. Two-dimensional color Doppler echocardiography may be a useful tool for anatomic evaluation to define its mechanism.


Asunto(s)
Insuficiencia de la Válvula Aórtica/complicaciones , Insuficiencia de la Válvula Mitral/etiología , Anciano , Insuficiencia de la Válvula Aórtica/diagnóstico por imagen , Diástole , Ecocardiografía Doppler en Color , Humanos , Masculino , Insuficiencia de la Válvula Mitral/diagnóstico por imagen
16.
Kaohsiung J Med Sci ; 17(10): 530-3, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11831117

RESUMEN

Very few investigators have studied the effect of contrast media on fibrinolysis. The results of those previous studies are contradictory and inconclusive. The purpose of this study was to evaluate the effect of ionic and nonionic contrast media on fibrinolysis in patients undergoing angiocardiography. Sixty-two patients randomly received either ionic contrast medium Hypaque-76 (n = 31) or nonionic contrast medium Ultravist-370 (n = 31). Plasma tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), fibrinogen, and D-dimer were measured before and 20 minutes after the procedures. A significant increase of PAI-1 levels was seen in the Ultravist group but not in the Hypaque group. The t-PA and fibrinogen levels remained virtually unchanged in both groups. A significant increase of D-dimer concentrations was observed in the Hypaque group but not in the Ultravist group. The results of this study may in part explain the reason that the ionic contrast media produce fewer thromboembolic complications than the nonionic contrast media during the cardiac catheterization.


Asunto(s)
Medios de Contraste/efectos adversos , Angiografía Coronaria , Fibrinólisis/efectos de los fármacos , Adulto , Anciano , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Humanos , Masculino , Persona de Mediana Edad , Inhibidor 1 de Activador Plasminogénico/sangre , Activador de Tejido Plasminógeno/sangre
17.
Kaohsiung J Med Sci ; 14(11): 706-9, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9838766

RESUMEN

This study tried to assess the probability of nasopharyngeal carcinoma (NPC) being present in adults with only otitis media with effusion (OME) and evaluate the necessity of nasopharyngeal biopsy in Taiwanese adults with only OME. The clinical features of patients with known OME were analyzed and the incidence of nasopharyngeal carcinoma in adults with only OME was assessed. The clinical features of 36 adults with OME but without other symptoms and signs suggestive of NPC who presented to the Kaohsiung Medical College Hospital Department of Otorhinolaryngology between December 1995 and February 1997 were analyzed. Two of these patients had biopsy-proven non-keratinizing carcinomas. OME was caused by upper respiratory infection in 8 patients (22.2%), chronic paranasal sinusitis in 5 (13.9%), allergic rhinitis in 5 (13.9%), NPC in 2 (5.6%), other etiologies in 5 (13.9%) and by unknown etiologies in 11 (30.5%). The incidence of NPC in adults with OME but no other symptoms and signs suggestive of NPC was 5.6% (2 out of 36 patients). It was higher than other reports because NPC has a high prevalence in Taiwan. Therefore, biopsy of the post-nasal space in adults with only OME when NPC is strongly suspected is necessary for the early diagnosis of NPC in Taiwan. We conclude that Taiwanese adults with only OME for which the cause is unclear should be subjected to an examination and biopsy of the nasopharynx to exclude NPC.


Asunto(s)
Neoplasias Nasofaríngeas/diagnóstico , Otitis Media con Derrame/etiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Nasofaríngeas/complicaciones , Probabilidad
18.
Kaohsiung J Med Sci ; 17(5): 239-44, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11517862

RESUMEN

Cardiac troponin-I (cTn-I) is a sensitive and specific marker for the diagnosis of acute myocardial infarction (AMI). However, elevation of serum cTn-I has been observed in some unstable angina patients who have a worse prognosis than those with normal serum cTn-I levels. It is unknown whether serum cTn-I can elevate in stable angina patients with acute ischemic burden. Therefore, the purpose of this study was to determine a serial change of cTn-I in patients with acute ischemia induced by a treadmill exercise test. Thirty-five patients suspected of having coronary artery disease and five healthy medical students were enrolled into this study. Every patient received a treadmill exercise test. Cardiac troponin-I was measured by fluorescent immunoassay before the treadmill test and at 5 minutes, 1 hour, 3 hours, and 6 hours after the treadmill test. Patients with cTn-I levels of less than 0.5 ng/ml were considered normal, and those with cTn-I levels of greater than 2.0 ng/ml was considered to have AMI. The exercise test was positive in 19 of the 35 patients and negative in 16 of the 35 patients and 5 medical students. Among the 19 patients with positive treadmill exercise test, the cTn-I concentrations were abnormally increased in 7/19 (37%) patients (mean: 1.1 +/- 0.4 ng/ml; range: 0.5 to 2.0 ng/ml). One of the 16 patients with negative treadmill test showed an increase of serum cTn-I. Normal cTn-I levels were found in the other 15 patients and the 5 medical students. In conclusion, serum cTn-I levels were found to increase to some extent in one third of stable angina patients who have an acute ischemic episode induced by treadmill exercise test.


Asunto(s)
Prueba de Esfuerzo , Isquemia Miocárdica/sangre , Miocardio/química , Troponina I/sangre , Anciano , Angina de Pecho/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad
19.
Kaohsiung J Med Sci ; 17(11): 579-81, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11852466

RESUMEN

Myxoma is the most common primary tumor of heart. The typical picture of myxoma under echocardiography is a solid, dense echo mass and left atrium is the most common site to find it. The cystic form of myxoma is vary rare. We report a patient who received echocardiographic examination under impression of mitral valve stenosis. A multilobulated cystic mass which was like a hydatid cyst was found in the left atrium and atrioventricular flow was affected by this mass. After tumor resection, myxoma with internal hemorrhage was proved by pathology. No further recurrent myxoma was found during follow-up echocardiographic examination.


Asunto(s)
Neoplasias Cardíacas/diagnóstico por imagen , Mixoma/diagnóstico por imagen , Anciano , Ecocardiografía , Femenino , Atrios Cardíacos , Neoplasias Cardíacas/cirugía , Humanos , Imagen por Resonancia Magnética , Mixoma/cirugía
20.
Kaohsiung J Med Sci ; 17(6): 336-9, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11559973

RESUMEN

The Kearns-Sayre (K-S) syndrome which includes the triad of progressive external ophthalmoplegia, pigment retinopathy, and disorder of cardiac conduction was first described in 1958. The mitochondria disorder is believed to be the cause of this syndrome. Involvement of the cardiac conduction system is the most importent prognostic factor in K-S syndrome. A 34-year-old male K-S syndrome patient, manifesting as ptosis and weakness of limbs since the age of 15 years, suffered from dizziness and weakness. Twelve-lead eletrocardiography (ECG) showed a 2:1 atrioventricular (AV) block with slow ventricular rate. Intermittent complete AV block, complete left bundle branch block and torsades de pointes were noted in Holter ECG. The electrophysiology study demonstrated prolonged HV interval (85 ms) on conduction beat and infra-His block on non-conduction beat. A VVIR mode of permanent pacemaker was implanted and the patient's condition was stable during this period of follow-up.


Asunto(s)
Bloqueo Cardíaco/etiología , Síndrome de Kearns-Sayre/complicaciones , Adulto , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda